Arden Anglican School wins SunSafe Ambassador competition
13 December 2018
Three students from Arden Anglican School in Epping have won Melanoma Institute Australia’s (MIA) inaugural SunSafe Student Ambassador Award for their engaging and inspiring presentation to their peers about how to be sun safe and help prevent melanoma.
Year 10 students Kaela (16), Oliver (16) and Kimberley (16) were nominated by their school to join other students at MIA’s one-day SunSafe Student Ambassador Program at The Poche Centre in Wollstonecraft, where they learned about melanoma and the importance of sun safety.
The program was also designed to assist students in developing their presentation skills, so they could create a personalised sun safe presentation to deliver at their school.
The students returned to their schools to deliver their own SunSafe presentation to their peers, with nine schools submitting videos of the student presentations for judging by MIA’s expert panel, including the Chair of MIA’s Education Committee Associate Professor Robyn Saw, Director of Speak Out Schools Kat Collins, and MIA CEO Matthew Browne.
The students from Arden Anglican School were announced as the winners and were today presented with their award at the final Year 10 Meeting for the year by Melanoma Institute Australia CEO Matthew Browne.
‘I thought the three Arden ambassadors were very engaging,’ said Mr. Browne.
‘Kaela, Oliver and Kimberley’s presentation would have undoubtedly convinced many of their peers to cover up and protect themselves from the sun, a critically important message particularly for teenagers.’
UV exposure leading to sunburn is the greatest risk factor for developing melanoma. One Australian dies every five hours from melanoma, which is also the most common cancer affecting 15 to 39 year old Australians.
MIA’s SunSafe Student Ambassador Program will be rolled out in six locations across east coast of Australia in late 2019. Schools interested in participating can fill out the expression of interest form here.
The 2021 Australasian Melanoma Conference (AMC2021) will held in Sydney, Australia.
A re-cap of the wonderful, and often very creative, community fundraising initiatives over the April to June quarter.
Our patients who donate their tissue samples and records to our research are helping to make a difference to the lives of future melanoma patients.
MIA researchers have recently been awarded two competitive funding grants, which will help facilitate their ground-breaking work in melanoma research.
Melanoma survivor Matt Kean is doing a 1000km bike ride around the Riverina this October, to increase awareness of melanoma and raise funds for Amie St Clair Melanoma - MIA. There are many ways you can be part of this life-changing ride!
Celebrate the 10th anniversary of Amie St Clair Melanoma at the Annual Ball in Wagga Wagga!
Riverina patients gain access to potentially life saving immunotherapy treatment close to home.
MIA's Prof Scolyer has been appointed as an Officer (AO) of the Order of Australia.
In a breakthrough which could extend to the treatment of other cancers, a new immune checkpoint inhibitor has proven effective in helping save the lives of advanced melanoma patients.
Whilst our research and clinical teams are trialling new treatments to save lives, it is our nurses who are on the front line providing care and support.
The easing of COVID restrictions has meant the return of community events, and we recognise the generous support of our community fundraisers.
Melanoma patients and their carers are being urged to participate in a ground-breaking survey which will shape the future of melanoma treatment, research, support and funding in Australia.
We have been buoyed by the wonderful support for our Melanoma March campaign, and our mission to cover Australia in footprints continues into April!
There was a wonderful feeling of community support amongst the melanoma patients, families and friends at the WA Melanoma Community Form.
The Price family has decided to share their story to inspire Australians to support research into new melanoma treatments.
New research has provided evidence in favour of a structured skin surveillance program for high-risk melanoma patients.
Melanoma research saved Bert's life at 101 and now he wants to give back.
A new MIA online risk calculator for clinicians can determine the likelihood of thin melanoma spreading.